Selected article for: "available vaccine and effective vaccine"
Author: Xin Zeng; Lingfang Li; Jing Lin; Xinlei Li; Bin Liu; Yang Kong; Shunze Zeng; Jianhua Du; Huahong Xiao; Tao Zhang; Shelin Zhang; Jianghai Liu
Title: Blocking antibodies against SARS-CoV-2 RBD isolated from a phage display antibody library using a competitive biopanning strategy
  • Document date: 2020_4_20
    • ID: 4w6caxwu_3
    Snippet: No effective cure or vaccine is currently available for COVID-19. Based on structure information above, blocking SARS-CoV-2 RBD is a rational therapeutic approach. Here we developed a competitive biopanning strategy to efficiently isolate blocking antibodies from phage display antibody libraries. Several high-affinity antibodies targeting SARS-CoV-2 RBD and blocking its binding to ACE2 were isolated, and the top 1 lead exhibited a neutralization .....
    Document: No effective cure or vaccine is currently available for COVID-19. Based on structure information above, blocking SARS-CoV-2 RBD is a rational therapeutic approach. Here we developed a competitive biopanning strategy to efficiently isolate blocking antibodies from phage display antibody libraries. Several high-affinity antibodies targeting SARS-CoV-2 RBD and blocking its binding to ACE2 were isolated, and the top 1 lead exhibited a neutralization activity of SARS-CoV-2 pseudotyped VSV infection.

    Search related documents:
    Co phrase search for related documents
    • antibody library and high affinity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • antibody library and high affinity antibody: 1, 2, 3, 4, 5, 6, 7, 8
    • antibody library and neutralization activity: 1, 2, 3, 4, 5, 6
    • antibody library and phage display: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody library and phage display antibody library: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antibody library and SARS RBD block: 1, 2
    • biopanning strategy and high affinity: 1, 2, 3, 4
    • biopanning strategy and high affinity antibody: 1
    • biopanning strategy and neutralization activity: 1, 2
    • biopanning strategy and phage display: 1, 2, 3, 4, 5
    • biopanning strategy and phage display antibody library: 1, 2, 3
    • biopanning strategy and SARS RBD block: 1, 2
    • block antibody and high affinity: 1
    • block antibody and neutralization activity: 1, 2
    • block antibody and phage display: 1
    • block antibody and SARS neutralization activity: 1
    • block antibody and structure information: 1
    • effective cure and structure information: 1
    • effective cure and therapeutic approach: 1